These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 16989735)
1. Increase in decorin and biglycan in Duchenne Muscular Dystrophy: role of fibroblasts as cell source of these proteoglycans in the disease. Fadic R; Mezzano V; Alvarez K; Cabrera D; Holmgren J; Brandan E J Cell Mol Med; 2006; 10(3):758-69. PubMed ID: 16989735 [TBL] [Abstract][Full Text] [Related]
2. Decorin and biglycan expression is differentially altered in several muscular dystrophies. Zanotti S; Negri T; Cappelletti C; Bernasconi P; Canioni E; Di Blasi C; Pegoraro E; Angelini C; Ciscato P; Prelle A; Mantegazza R; Morandi L; Mora M Brain; 2005 Nov; 128(Pt 11):2546-55. PubMed ID: 16183658 [TBL] [Abstract][Full Text] [Related]
3. Altered production of extra-cellular matrix components by muscle-derived Duchenne muscular dystrophy fibroblasts before and after TGF-beta1 treatment. Zanotti S; Gibertini S; Mora M Cell Tissue Res; 2010 Feb; 339(2):397-410. PubMed ID: 19902258 [TBL] [Abstract][Full Text] [Related]
4. Non-Glycanated Biglycan and LTBP4: Leveraging the extracellular matrix for Duchenne Muscular Dystrophy therapeutics. Fallon JR; McNally EM Matrix Biol; 2018 Aug; 68-69():616-627. PubMed ID: 29481844 [TBL] [Abstract][Full Text] [Related]
5. Biglycan and decorin induce morphological and cytoskeletal changes involving signalling by the small GTPases RhoA and Rac1 resulting in lung fibroblast migration. Tufvesson E; Westergren-Thorsson G J Cell Sci; 2003 Dec; 116(Pt 23):4857-64. PubMed ID: 14600270 [TBL] [Abstract][Full Text] [Related]
6. Small proteoglycans of normal adult human kidney: distinct expression patterns of decorin, biglycan, fibromodulin, and lumican. Schaefer L; Gröne HJ; Raslik I; Robenek H; Ugorcakova J; Budny S; Schaefer RM; Kresse H Kidney Int; 2000 Oct; 58(4):1557-68. PubMed ID: 11012890 [TBL] [Abstract][Full Text] [Related]
7. Differential expression of small chondroitin/dermatan sulfate proteoglycans, PG-I/biglycan and PG-II/decorin, by vascular smooth muscle and endothelial cells in culture. Järveläinen HT; Kinsella MG; Wight TN; Sandell LJ J Biol Chem; 1991 Dec; 266(34):23274-81. PubMed ID: 1744124 [TBL] [Abstract][Full Text] [Related]
8. Transient up-regulation of biglycan during skeletal muscle regeneration: delayed fiber growth along with decorin increase in biglycan-deficient mice. Casar JC; McKechnie BA; Fallon JR; Young MF; Brandan E Dev Biol; 2004 Apr; 268(2):358-71. PubMed ID: 15063173 [TBL] [Abstract][Full Text] [Related]
9. Differential regulation of decorin and biglycan gene expression by dexamethasone and retinoic acid in cultured human skin fibroblasts. Kähäri VM; Häkkinen L; Westermarck J; Larjava H J Invest Dermatol; 1995 Apr; 104(4):503-8. PubMed ID: 7706767 [TBL] [Abstract][Full Text] [Related]
10. Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers-Danlos syndrome patient carrying the novel Arg270Cys substitution in galactosyltransferase I (beta4GalT-7). Seidler DG; Faiyaz-Ul-Haque M; Hansen U; Yip GW; Zaidi SH; Teebi AS; Kiesel L; Götte M J Mol Med (Berl); 2006 Jul; 84(7):583-94. PubMed ID: 16583246 [TBL] [Abstract][Full Text] [Related]
11. TGF-beta modulates the synthesis of proteoglycans by myocardial fibroblasts in culture. Heimer R; Bashey RI; Kyle J; Jimenez SA J Mol Cell Cardiol; 1995 Oct; 27(10):2191-8. PubMed ID: 8576935 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of proteoglycans is augmented in dystrophic mdx mouse skeletal muscle. Cáceres S; Cuellar C; Casar JC; Garrido J; Schaefer L; Kresse H; Brandan E Eur J Cell Biol; 2000 Mar; 79(3):173-81. PubMed ID: 10777109 [TBL] [Abstract][Full Text] [Related]
14. Anti-fibrotic effect of pirfenidone in muscle derived-fibroblasts from Duchenne muscular dystrophy patients. Zanotti S; Bragato C; Zucchella A; Maggi L; Mantegazza R; Morandi L; Mora M Life Sci; 2016 Jan; 145():127-36. PubMed ID: 26679108 [TBL] [Abstract][Full Text] [Related]
15. Platelet-derived growth factor and transforming growth factor-beta 1 differentially affect the synthesis of biglycan and decorin by monkey arterial smooth muscle cells. Schönherr E; Järveläinen HT; Kinsella MG; Sandell LJ; Wight TN Arterioscler Thromb; 1993 Jul; 13(7):1026-36. PubMed ID: 8318504 [TBL] [Abstract][Full Text] [Related]
16. Altered extracellular matrix transcript expression and protein modulation in primary Duchenne muscular dystrophy myotubes. Zanotti S; Saredi S; Ruggieri A; Fabbri M; Blasevich F; Romaggi S; Morandi L; Mora M Matrix Biol; 2007 Oct; 26(8):615-24. PubMed ID: 17662584 [TBL] [Abstract][Full Text] [Related]
17. WISP-1 binds to decorin and biglycan. Desnoyers L; Arnott D; Pennica D J Biol Chem; 2001 Dec; 276(50):47599-607. PubMed ID: 11598131 [TBL] [Abstract][Full Text] [Related]
18. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy. Ito M; Ehara Y; Li J; Inada K; Ohno K Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975 [TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor regulates proteoglycan synthesis in interstitial fibroblasts. Kobayashi E; Sasamura H; Mifune M; Shimizu-Hirota R; Kuroda M; Hayashi M; Saruta T Kidney Int; 2003 Oct; 64(4):1179-88. PubMed ID: 12969135 [TBL] [Abstract][Full Text] [Related]
20. Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung. Kolb M; Margetts PJ; Sime PJ; Gauldie J Am J Physiol Lung Cell Mol Physiol; 2001 Jun; 280(6):L1327-34. PubMed ID: 11350814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]